CT45A5 Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)
-
- Target See all CT45A5 Proteins
- CT45A5 (Cancer/testis Antigen Family 45, Member A5 (CT45A5))
- Protein Type
- Recombinant
- Protein Characteristics
- Transcript Variant 2
- Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This CT45A5 protein is labelled with Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Characteristics
-
- Recombinant human Cancer/testis antigen family 45, member A5 (CT45A5), transcript variant 2. (transcript variant 2) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Purity
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product CT45A5 Protein
-
-
- Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Comment
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Storage
- -80 °C
- Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Target
- CT45A5 (Cancer/testis Antigen Family 45, Member A5 (CT45A5))
- Abstract
- CT45A5 Products
- Synonyms
- CT45.5 Protein, CT455 Protein, cancer/testis antigen family 45 member A5 Protein, CT45A5 Protein
- Background
- This gene represents one of a cluster of several similar genes located on the q arm of chromosome X. The genes in this cluster encode members of the cancer/testis (CT) family of antigens, and are distinct from other CT antigens. These antigens are thought to be novel therapeutic targets for human cancers. Alternative splicing results in multiple transcript variants.
- Molecular Weight
- 21.7
- NCBI Accession
- NP_001165759
-